Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9643 |
High Similarity |
NPD8053 |
Approved |
0.9643 |
High Similarity |
NPD8054 |
Approved |
0.9458 |
High Similarity |
NPD8252 |
Approved |
0.9458 |
High Similarity |
NPD8099 |
Discontinued |
0.9458 |
High Similarity |
NPD8251 |
Approved |
0.9401 |
High Similarity |
NPD8156 |
Discontinued |
0.8743 |
High Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.8486 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.8313 |
Intermediate Similarity |
NPD4584 |
Approved |
0.8256 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7906 |
Approved |
0.8035 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.788 |
Intermediate Similarity |
NPD7312 |
Approved |
0.788 |
Intermediate Similarity |
NPD7313 |
Approved |
0.788 |
Intermediate Similarity |
NPD7310 |
Approved |
0.788 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7874 |
Intermediate Similarity |
NPD7298 |
Approved |
0.7838 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7821 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7803 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7784 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7754 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7735 |
Intermediate Similarity |
NPD27 |
Approved |
0.7735 |
Intermediate Similarity |
NPD2489 |
Approved |
0.773 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7709 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7684 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7616 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7616 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7602 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7598 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7572 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD1424 |
Approved |
0.756 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7557 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7542 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7541 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7514 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7457 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7457 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7446 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7432 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7401 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7399 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7377 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7377 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7374 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7374 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7374 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7374 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7326 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.7323 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD6997 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7268 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7268 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7265 |
Intermediate Similarity |
NPD8152 |
Approved |
0.7265 |
Intermediate Similarity |
NPD8153 |
Approved |
0.7264 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7264 |
Intermediate Similarity |
NPD4582 |
Approved |
0.725 |
Intermediate Similarity |
NPD5006 |
Approved |
0.725 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7047 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7236 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7214 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7214 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7207 |
Intermediate Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7188 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD3837 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7159 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7135 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.71 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7098 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7068 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7062 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7041 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7024 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7018 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7018 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7493 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7590 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6994 |
Remote Similarity |
NPD6896 |
Approved |
0.6994 |
Remote Similarity |
NPD6895 |
Approved |
0.6989 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD4237 |
Approved |
0.6989 |
Remote Similarity |
NPD3060 |
Approved |
0.6989 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6983 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD4166 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD4873 |
Discontinued |
0.6959 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4585 |
Approved |
0.6954 |
Remote Similarity |
NPD1753 |
Discontinued |
0.6952 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6947 |
Remote Similarity |
NPD5938 |
Phase 3 |
0.6944 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD7438 |
Suspended |
0.694 |
Remote Similarity |
NPD5090 |
Approved |
0.694 |
Remote Similarity |
NPD5089 |
Approved |
0.6935 |
Remote Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD4040 |
Phase 1 |
0.6916 |
Remote Similarity |
NPD7907 |
Approved |
0.6915 |
Remote Similarity |
NPD6284 |
Clinical (unspecified phase) |
0.6911 |
Remote Similarity |
NPD7177 |
Discontinued |
0.691 |
Remote Similarity |
NPD2677 |
Approved |
0.6906 |
Remote Similarity |
NPD7427 |
Discontinued |
0.6904 |
Remote Similarity |
NPD7291 |
Discontinued |
0.6893 |
Remote Similarity |
NPD4162 |
Approved |
0.6889 |
Remote Similarity |
NPD7020 |
Approved |
0.6889 |
Remote Similarity |
NPD7019 |
Approved |
0.6882 |
Remote Similarity |
NPD7773 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD7030 |
Discontinued |
0.6875 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6865 |
Remote Similarity |
NPD2978 |
Approved |
0.6865 |
Remote Similarity |
NPD2977 |
Approved |
0.6862 |
Remote Similarity |
NPD2904 |
Discontinued |
0.686 |
Remote Similarity |
NPD7477 |
Discontinued |
0.6854 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.6851 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6851 |
Remote Similarity |
NPD52 |
Approved |
0.6851 |
Remote Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.6851 |
Remote Similarity |
NPD7526 |
Approved |
0.685
|
Remote Similarity |
NPD7125 |
Discontinued |